BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33102233)

  • 1. Assessment of Ablative Margin After Microwave Ablation for Hepatocellular Carcinoma Using Deep Learning-Based Deformable Image Registration.
    An C; Jiang Y; Huang Z; Gu Y; Zhang T; Ma L; Huang J
    Front Oncol; 2020; 10():573316. PubMed ID: 33102233
    [No Abstract]   [Full Text] [Related]  

  • 2. The tumor ghost on MRI after microwave ablation for hepatocellular carcinoma: A new modality to assess the ablative margin.
    Liu S; Wu J; Ding W; Zhang C; Luo Y; Bai X; Wen K; Han Z; Yu J; Liang P
    Eur J Radiol; 2023 Jan; 158():110617. PubMed ID: 36463706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablative margin quantification using deformable versus rigid image registration in colorectal liver metastasis thermal ablation: a retrospective single-center study.
    Lin YM; Paolucci I; Albuquerque Marques Silva J; O'Connor CS; Hong J; Shah KY; Abdelsalam ME; Habibollahi P; Jones KA; Brock KK; Odisio BC
    Eur Radiol; 2024 Feb; ():. PubMed ID: 38334762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
    Joo I; Morrow KW; Raman SS; McWilliams JP; Sayre JW; Lu DS
    Eur Radiol; 2022 Sep; 32(9):6327-6335. PubMed ID: 35389047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study.
    Li FY; Li JG; Wu SS; Ye HL; He XQ; Zeng QJ; Zheng RQ; An C; Li K
    J Hepatocell Carcinoma; 2021; 8():1375-1388. PubMed ID: 34815974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging.
    Jiang C; Liu B; Chen S; Peng Z; Xie X; Kuang M
    Int J Hyperthermia; 2018 Dec; 34(8):1135-1141. PubMed ID: 29392978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tumor map generated from three-dimensional visualization of image fusion for the assessment of microwave ablation of hepatocellular carcinoma: a preliminary study.
    An C; Li X; Liang P; Yu J; Cheng Z; Han Z; Liu F; Dong L
    Cancer Manag Res; 2019; 11():1569-1578. PubMed ID: 30863167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of safety margin after microwave ablation of stage I NSCLC with three-dimensional reconstruction technique using CT imaging.
    Yan P; Tong AN; Nie XL; Ma MG
    BMC Med Imaging; 2021 Jun; 21(1):96. PubMed ID: 34098894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Value of Ablative Margin Assessment After Microwave Ablation for Local Tumor Progression in Medium and Large Hepatocellular Carcinoma: Computed Tomography-Computed Tomography Image Fusion Method Versus Side-by-Side Method.
    Zhou H; Yang G; Jing X; Zhou Y; Ding J; Wang Y; Wang F; Zhao L
    J Comput Assist Tomogr; 2023 Jan-Feb 01; 47(1):31-37. PubMed ID: 36668979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
    Laimer G; Schullian P; Jaschke N; Putzer D; Eberle G; Alzaga A; Odisio B; Bale R
    Eur Radiol; 2020 May; 30(5):2463-2472. PubMed ID: 32002642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma.
    Li K; Su ZZ; Xu EJ; Ju JX; Meng XC; Zheng RQ
    BMC Cancer; 2016 Apr; 16():277. PubMed ID: 27090513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional contrast-enhanced ultrasound fusion imaging predicts local tumor progression by evaluating ablative margin of radiofrequency ablation for hepatocellular carcinoma: a preliminary report.
    Ye J; Huang G; Zhang X; Xu M; Zhou X; Lin M; Xie X; Xie X
    Int J Hyperthermia; 2019; 36(1):55-64. PubMed ID: 30444428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microwave Ablation (MWA) of Pulmonary Neoplasms: Clinical Performance of High-Frequency MWA With Spatial Energy Control Versus Conventional Low-Frequency MWA.
    Vogl TJ; Basten LM; Nour-Eldin NA; Kaltenbach B; Ackermann H; Naguib NNN
    AJR Am J Roentgenol; 2019 Dec; 213(6):1388-1396. PubMed ID: 31593520
    [No Abstract]   [Full Text] [Related]  

  • 14. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Margin Estimates Predict Local Tumor Progression Following Microwave Ablation of Small Renal Masses.
    Iheanacho F; Rex N; Oueidat K; Collins S; Baird GL; Kim D; Dubel GJ; Jay BS; Maxwell AWP
    Cardiovasc Intervent Radiol; 2024 Feb; 47(2):200-207. PubMed ID: 38151603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Microwave Ablation of Hepatocellular Carcinoma: The Impact of Tumor Size and Minimal Ablative Margin on Therapeutic Success.
    Pausch AM; Ghali T; Wertheimer T; Zeman F; Mueller K; Doppler MC; Einspieler I; Beyer LP; Schleder S; Stroszczynski C; Luerken L
    Tomography; 2022 Dec; 9(1):50-59. PubMed ID: 36648992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous ablative therapies for hepatocellular carcinoma in the caudate lobe of the liver: efficacy and outcome.
    Mukund A; Tripathy TP; Patel RK; Chandel K; Patidar Y; Jindal A; Sarin SK
    Br J Radiol; 2023 Aug; 96(1148):20220086. PubMed ID: 37227887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
    Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
    Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
    Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.